[FG] Grosse Gerrit

Damke, Kristian et al. (2025) ‘Woman With Unilateral Facial Paleness’, Annals of Emergency Medicine, 85(4), pp. 364–365. Available at: https://doi.org/10.1016/j.annemergmed.2024.10.009.

Diener, Hans Christoph et al. (2025) ‘Neue Studiendaten zur Primär- und Sekundärprävention des Schlaganfalls’, Fortschritte der Neurologie · Psychiatrie, 93(03), pp. 104–115. Available at: https://doi.org/10.1055/a-2465-8151.

Große, Gerrit M. (2025) ‘Zusätzlich intraarterielle Tenecteplase?’, InFo Neurologie + Psychiatrie, 27(3), pp. 31–31. Available at: https://doi.org/10.1007/s15005-025-4288-5.

Große, Gerrit M. and Diener, Hans-Christoph (2025) ‘Evidenzbasierte Prophylaxe mit Thrombozytenfunktionshemmern’, InFo Neurologie + Psychiatrie, 27(3), pp. 40–49. Available at: https://doi.org/10.1007/s15005-025-4267-x.

Grosse, Gerrit M. et al. (2025) ‘Prior Anticoagulation and Risk of Hemorrhagic Transformation in Acute Stroke: A Post Hoc Analysis of the PRODAST Study’, Journal of the American Heart Association , 14(3). Available at: https://doi.org/10.1161/JAHA.124.037014.

Große, Gerrit M. (2025) ‘Früher Beginn der Antikoagulation ist späterer Initiierung nicht unterlegen’, InFo Neurologie + Psychiatrie, 27(1), pp. 11–11. Available at: https://doi.org/10.1007/s15005-024-4219-x.

Große, Gerrit M. (2025) ‘Thrombektomie innerhalb von 24 Stunden?’, InFo Neurologie + Psychiatrie, 27(1), pp. 20–20. Available at: https://doi.org/10.1007/s15005-024-4214-2.

Große, Gerrit M. (2024) ‘Verbesserte Sekundärprävention?’, InFo Neurologie + Psychiatrie, 26(12), pp. 18–18. Available at: https://doi.org/10.1007/s15005-024-4181-7.

Jendretzky, Konstantin F. et al. (2024) ‘Clinical and paraclinical characteristics of optic neuritis in the context of the McDonald criteria 2017’, Scientific Reports, 14(1). Available at: https://doi.org/10.1038/s41598-024-57199-4.

Große, Gerrit M. (2024) ‘Dekompressive Kraniektomie wohl effektiv’, InFo Neurologie + Psychiatrie, 26(10), pp. 34–34. Available at: https://doi.org/10.1007/s15005-024-4080-y.

Große, Gerrit M. (2024) ‘Zerebrale Kavernome konservativ oder interventionell behandeln?’, InFo Neurologie + Psychiatrie, 26(10), pp. 17–17. Available at: https://doi.org/10.1007/s15005-024-4105-6.

Cao, Jiayu et al. (2024) ‘DNA-sensing inflammasomes cause recurrent atherosclerotic stroke’, Nature, 633(8029), pp. 433–441. Available at: https://doi.org/10.1038/s41586-024-07803-4.

Diener, H.-C. et al. (2024) ‘Efficacy and safety of oral factor Xa inhibitors versus vitamin-K antagonists in the early phase after acute ischemic stroke or TIA in the real-world setting: The PRODAST study’, European Stroke Journal, 9(3), pp. 696–703. Available at: https://doi.org/10.1177/23969873241242239.

Große, Gerrit M. (2024) ‘Colchicin nicht wirksamer als Placebo’, InFo Neurologie + Psychiatrie, 26(9), pp. 11–11. Available at: https://doi.org/10.1007/s15005-024-4085-6.

Diener, Hans-Christoph and Große, Gerrit M. (2024) ‘Neues zur Thrombolyse zur Akuttherapie des ischämischen Schlaganfalls’, InFo Neurologie + Psychiatrie, 26(7-8), pp. 28–36. Available at: https://doi.org/10.1007/s15005-024-3980-1.

Große, Gerrit M. (2024) ‘Auch bei großen Infarkten wirksam’, InFo Neurologie + Psychiatrie, 26(7-8), pp. 14–14. Available at: https://doi.org/10.1007/s15005-024-4038-0.

Baumann, Tristan et al. (2024) ‘Assessment of associations between neutrophil extracellular trap biomarkers in blood and thrombi in acute ischemic stroke patients’, Journal of Thrombosis and Thrombolysis, 57(6), pp. 936–946. Available at: https://doi.org/10.1007/s11239-024-03004-y.

Connolly, Stuart J. et al. (2024) ‘Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage’, New England Journal of Medicine, 390(19), pp. 1745–1755. Available at: https://doi.org/10.1056/NEJMoa2313040.

Große, Gerrit M. (2024) ‘Glykoprotein-VI-Inhibition ist sicher und könnte schwere Ereignisse verhindern’, InFo Neurologie + Psychiatrie, 26(4), pp. 23–23. Available at: https://doi.org/10.1007/s15005-024-3930-y.

Große, Gerrit M. (2024) ‘Apixaban ist ASS in der Sekundärprävention nicht überlegen’, InFo Neurologie + Psychiatrie, 26(3), pp. 24–25. Available at: https://doi.org/10.1007/s15005-024-3877-z.

Jochmann, Svenja L. et al. (2024) ‘Sex-Specific Risk Factors of Nonstenotic Carotid Plaque in Embolic Stroke of Unknown Source: A Case-Control Study’, Stroke, 55(2), pp. 296–300. Available at: https://doi.org/10.1161/STROKEAHA.123.044833.

Smith, Eric E. et al. (2024) ‘Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes’, Stroke, 55(2), pp. 392–402. Available at: https://doi.org/10.1161/STROKEAHA.123.043198.

Dirks, M. et al. (2024) ‘Long-Term Follow-Up of Neuropsychiatric Symptoms After Sustained Virological Response to Interferon-Free and Interferon-Based Hepatitis C Virus Treatment’, Journal of Viral Hepatitis [Preprint]. Available at: https://doi.org/10.1111/jvh.14033.

Große, Gerrit M. (2024) ‘Behinderung und Mortalität reduziert’, InFo Neurologie + Psychiatrie, 26(1), pp. 12–13. Available at: https://doi.org/10.1007/s15005-023-3811-9.

Grosse, Gerrit M et al. (2023) ‘Early or late initiation of dabigatran versus vitamin-K-antagonists in acute ischemic stroke or TIA: The PRODAST study’, International Journal of Stroke, 18(10), pp. 1169–1177. Available at: https://doi.org/10.1177/17474930231184366.

Hupe, J. et al. (2023) ‘Interplay between driveline infection, vessel wall inflammation, cerebrovascular events and mortality in patients with left ventricular assist device’, Scientific Reports, 13(1). Available at: https://doi.org/10.1038/s41598-023-45110-6.

Worthmann, Hans, Ernst, Johanna and Grosse, Gerrit M. (2023) ‘What is confirmed in the treatment of ischemic stroke Was ist gesichert in der Therapie des ischämischen Schlaganfalls?’, Innere Medizin (Germany), 64(12), pp. 1143–1153. Available at: https://doi.org/10.1007/s00108-023-01622-x.

Große, Gerrit M. (2023) ‘Thrombolyse ist trotz NOAK-Therapie sicher’, InFo Neurologie + Psychiatrie, 25(9), pp. 10–10. Available at: https://doi.org/10.1007/s15005-023-3399-0.

Sievering, Esther MW et al. (2023) ‘Diagnostic value of carotid intima-media thickness and clinical risk scores in determining etiology of ischemic stroke’, European Stroke Journal, 8(3), pp. 738–746. Available at: https://doi.org/10.1177/23969873231182492.

Ernst, Johanna et al. (2023) ‘Unraveling Mechanisms of Cryptogenic Stroke at the Genetic Level: A Systematic Literature Review’, Journal of the American Heart Association, 12(15). Available at: https://doi.org/10.1161/JAHA.123.029843.

Große, Gerrit M. (2023) ‘Orale Antikoagulanzien senken das Demenzrisiko’, InFo Neurologie + Psychiatrie, 25(7-8), pp. 14–14. Available at: https://doi.org/10.1007/s15005-023-3332-6.

Diener, Hans-Christoph et al. (2023) ‘Something new about stroke 2022-2023 Neues beim Schlaga 2022–2023’, Neurologie Up2date, 6(2), pp. 121–137. Available at: https://doi.org/10.1055/a-2031-0587.

Ravenberg, K.K. et al. (2023) ‘Microembolic signal monitoring in patients with HeartMate 3 and HeartWare left ventricular assist devices: Association with antithrombotic treatment and cerebrovascular events’, Artificial Organs, 47(2), pp. 370–379. Available at: https://doi.org/10.1111/aor.14409.

Grosse, Gerrit M. et al. (2023) ‘ADAMTS-13 activity in stroke of known and unknown cause: Relation to vascular risk factor burden’, Frontiers in Neurology, 13. Available at: https://doi.org/10.3389/fneur.2022.1045478.

Döring, K. et al. (2023) ‘Early clinical experience with the new generation Pipeline Vantage flow diverter in the treatment of unruptured saccular aneurysms using short-term dual antiplatelet therapy’, Interventional Neuroradiology [Preprint]. Available at: https://doi.org/10.1177/15910199231205047.

Sieweke, J.-T. et al. (2022) ‘Circulating fibroblast activation protein α is reduced in acute ischemic stroke’, Frontiers in Cardiovascular Medicine, 9. Available at: https://doi.org/10.3389/fcvm.2022.1064157.

Faber, D. et al. (2022) ‘Towards the Validation of Executive Functioning Assessments: A Clinical Study’, Journal of Clinical Medicine, 11(23). Available at: https://doi.org/10.3390/jcm11237138.

Hasse, Isabel M. C. et al. (2022) ‘Circulating Inflammatory Biomarkers in Early Prediction of Stroke-Associated Infections’, International Journal of Molecular Sciences, 23(22). Available at: https://doi.org/10.3390/ijms232213747.

de Buhr, Nicole et al. (2022) ‘Insights Into Immunothrombotic Mechanisms in Acute Stroke due to Vaccine-Induced Immune Thrombotic Thrombocytopenia’, Frontiers in Immunology, 13. Available at: https://doi.org/10.3389/fimmu.2022.879157.

Grosse, Gerrit M. et al. (2022) ‘Endogenous Deoxyribonuclease Activity and Cell-Free Deoxyribonucleic Acid in Acute Ischemic Stroke: A Cohort Study’, Stroke, 53(4), pp. 1235–1244. Available at: https://doi.org/10.1161/STROKEAHA.121.036299.

Grosse, Gerrit M. et al. (2022) ‘Circulating Cytokines and Growth Factors in Acute Cerebral Large Vessel Occlusion-Association with Success of Endovascular Treatment’, Thrombosis and Haemostasis, 122(4), pp. 623–632. Available at: https://doi.org/10.1055/a-1544-5431.

Sieweke, J.-T. et al. (2022) ‘Echocardiographic Parameters to Predict Atrial Fibrillation in Clinical Routine—The EAHsy-AF Risk Score’, Frontiers in Cardiovascular Medicine, 9. Available at: https://doi.org/10.3389/fcvm.2022.851474.

Ernst, J. et al. (2022) ‘Advancement of door-to-needle times in acute stroke treatment after repetitive process analysis: never give up!’, Therapeutic Advances in Neurological Disorders, 15. Available at: https://doi.org/10.1177/17562864221122491.

Dirks, M. et al. (2021) ‘Reduced microglia activity in patients with long-term immunosuppressive therapy after liver transplantation’, European Journal of Nuclear Medicine and Molecular Imaging, 49(1), pp. 234–245. Available at: https://doi.org/10.1007/s00259-021-05398-w.

Grosse, Gerrit M. et al. (2021) ‘Rationale, Design and Methods of the Prospective Record of the Use of Dabigatran in Patients with Acute Stroke or TIA (PRODAST) Study’, European Stroke Journal, 6(4), pp. 438–444. Available at: https://doi.org/10.1177/23969873211060219.

Grosse, Gerrit M. et al. (2021) ‘Circulating microRNAs in Symptomatic and Asymptomatic Carotid Stenosis’, Frontiers in Neurology, 12. Available at: https://doi.org/10.3389/fneur.2021.755827.

Deutsch, N.R. et al. (2021) ‘Autoantibodies against the NMDAR subunit NR1 are associated with neuropsychiatric outcome after ischemic stroke’, Brain, Behavior, and Immunity, 96, pp. 73–79. Available at: https://doi.org/10.1016/j.bbi.2021.05.011.

Gerrit M. Grosse and Hans-Christoph-Diener (2021) ‘Ischämischer Schlaganfall: Was ist heute State of the Art?’, Ärztliches Journal [Preprint].

Weissenborn, K. et al. (2021) ‘Endovascular Treatment of Acute Ischemic Stroke in Clinical Practice: Analysis of Workflow and Outcome in a Tertiary Care Center’, Frontiers in Neurology, 12. Available at: https://doi.org/10.3389/fneur.2021.657345.

Große, Gerrit M., Weimar, Christian and Diener, Hans-Christoph (2021) ‘Beginn der Antikoagulation nach akutem Schlaganfall’, InFo Neurologie + Psychiatrie, 23(1), pp. 38–49. Available at: https://doi.org/10.1007/s15005-020-1784-5.

Grosse, Gerrit M. et al. (2020) ‘Nonstenotic Carotid Plaque in Embolic Stroke of Undetermined Source: Interplay of Arterial and Atrial Disease’, Stroke, 51(12), pp. 3737–3741. Available at: https://doi.org/10.1161/STROKEAHA.120.030537.

Stauss, Ricarda D. et al. (2020) ‘Distinct systemic cytokine networks in symptomatic and asymptomatic carotid stenosis’, Scientific Reports, 10(1). Available at: https://doi.org/10.1038/s41598-020-78941-8.

Sieweke, J.-T. et al. (2020) ‘MiR−21 and nt-probnp correlate with echocardiographic parameters of atrial dysfunction and predict atrial fibrillation’, Journal of Clinical Medicine, 9(4). Available at: https://doi.org/10.3390/jcm9041118.

Grosse, Gerrit M. et al. (2020) ‘Identification of a rare SEPT9 variant in a family with autosomal dominant Charcot-Marie-Tooth disease’, BMC Medical Genetics, 21(1). Available at: https://doi.org/10.1186/s12881-020-0984-7.

Grosse, Gerrit M. et al. (2020) ‘Arginine derivatives in cerebrovascular diseases: Mechanisms and clinical implications’, International Journal of Molecular Sciences, 21(5). Available at: https://doi.org/10.3390/ijms21051798.

van Gemmeren, T. et al. (2020) ‘Early post-stroke infections are associated with an impaired function of neutrophil granulocytes’, Journal of Clinical Medicine, 9(3). Available at: https://doi.org/10.3390/jcm9030872.

Sieweke, Jan-Thorben et al. (2020) ‘Septal total atrial conduction time for prediction of atrial fibrillation in embolic stroke of unknown source: a pilot study’, Clinical Research in Cardiology, 109(2), pp. 205–214. Available at: https://doi.org/10.1007/s00392-019-01501-2.

Putzer, A.-S. et al. (2020) ‘ADAMTS13 activity is associated with early neurological improvement in acute ischemic stroke patients treated with intravenous thrombolysis’, Journal of Thrombosis and Thrombolysis, 49(1), pp. 67–74. Available at: https://doi.org/10.1007/s11239-019-01941-7.

Ziegler, Nora L. et al. (2019) ‘Markers of endothelial pathology to support detection of atrial fibrillation in embolic stroke of undetermined source’, Scientific Reports, 9(1). Available at: https://doi.org/10.1038/s41598-019-55943-9.

Grosse, Gerrit M. et al. (2019) ‘Plasma dimethylarginine levels and carotid intima–media thickness are related to atrial fibrillation in patients with embolic stroke’, International Journal of Molecular Sciences, 20(3). Available at: https://doi.org/10.3390/ijms20030730.

Kasner S.E. et al. (2018) ‘Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial’, The Lancet Neurology, 17(12), pp. 1053–1060. Available at: https://doi.org/10.1016/s1474-4422(18)30319-3.

Claiborne Johnston, S. et al. (2018) ‘Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA’, New England Journal of Medicine, 379(3), pp. 215–225. Available at: https://doi.org/10.1056/NEJMoa1800410.

Hart RG et al. (2018) ‘Rivaroxaban for stroke prevention after embolic stroke of undetermined source’, New England Journal of Medicine. 16.05.2018, 378(23), pp. 2191–2201. Available at: https://doi.org/10.1056/NEJMoa1802686.

Schuppner, R. et al. (2018) ‘ADAMTS-13 Activity Predicts Outcome in Acute Ischaemic Stroke Patients Undergoing Endovascular Treatment’, Thrombosis and Haemostasis, 118(4), pp. 758–767. Available at: https://doi.org/10.1055/s-0038-1637732.

Grosse, Gerrit M. et al. (2018) ‘Targeting chemokine receptor CXCR4 and translocator protein for characterization of high-risk plaque in carotid stenosis ex vivo’, Stroke, 49(8), pp. 1988–1991. Available at: https://doi.org/10.1161/STROKEAHA.118.021070.

Grosse, Gerrit M. et al. (2016) ‘Monocyte subsets and related chemokines in carotid artery stenosis and ischemic stroke’, International Journal of Molecular Sciences, 17(4). Available at: https://doi.org/10.3390/ijms17040433.

Grosse, G.M. et al. (2014) ‘Re. “identification of patients with a histologically unstable carotid plaque using ultrasonic plaque image analysis”’, European Journal of Vascular and Endovascular Surgery, 48(6), pp. 714–715. Available at: https://doi.org/10.1016/j.ejvs.2014.09.013.

Grosse, Gerrit M. et al. (2014) ‘The temporal dynamics of plasma fractalkine levels in ischemic stroke: Association with clinical severity and outcome’, Journal of Neuroinflammation, 11. Available at: https://doi.org/10.1186/1742-2094-11-74.